Navigation Links
CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008
Date:2/5/2009

icularly strong in the fourth quarter with purchases by General Electric Medical Systems (GEMS) of 72 ICG Modules and Mindray of 80 ICG Modules. The Company also received a firm purchase order in January 2009 from Mindray for an additional 150 ICG Modules deliverable in 2009.

ICG sensor revenue in the fourth quarter was a record $1.9 million, due in part to the clinical sales team's focused customer service efforts through the launch of the Comprehensive Customer Care (C3) and ICG CERTIFIED programs.

Gross margin as a percentage of sales increased from 68% to 72% in fiscal 2008, largely due to lower manufacturing overhead costs, 9% average unit sales price improvement, and lower inventory reserve requirements.

As part of the Company's efforts to accelerate the return to profitability, tight expense control resulted in a 1% overall reduction in 2008 operating expenses with the most significant savings occurring in non revenue generating areas including General and Administrative expenses, down $321,000 and Research and Development, down $188,000. The Company surpassed one of its major 2008 goals by achieving $276,000 of positive operating cash flow in the fourth quarter of 2008.

Fourth Quarter 2008 operating loss improved 47% to $442,000, down from an operating loss of $830,000 in fourth quarter 2007. The operating loss for fiscal 2008 was $2.0 million, a 58% improvement from fiscal 2007 operating loss of $4.8 million. Fiscal 2008 loss before income taxes, depreciation, amortization and equity compensation was $1.0 million, an improvement of $2.9 million, or 74%

CEO Comments and Outlook

"We were pleased with the continued improvement in our key operating metrics during the fourth quarter and throughout 2008," stated Michael K. Perry, Chief Executive Officer of CardioDynamics. "Despite the challenging business climate, we achieved our eighth consecutive
'/>"/>

SOURCE CardioDynamics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities
2. CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 2008
3. CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast
4. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
5. CardioDynamics Reports 22% Revenue Growth in First Quarter 2008
6. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
7. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
8. CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India
9. CardioDynamics Announces Third Quarter 2007 Conference Call and Webcast
10. Cepheid Reports Fourth Quarter and Full Year 2008 Results
11. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... San Diego, Calif. (April 18, 2014) ― A new ... analyzing weekly patterns in health-related Google searches reveals ... public health strategies. , Investigators from San ... University, and the Monday Campaigns, analyzed "healthy" Google searches ... health-related, e.g., "healthy diet") originating in the U.S. from ...
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... In the April issue of Experimental Biology ... by Drs. Rex Gaskins and Paul Kenis in ... campus of the University of Illinois Urbana-Champaign describe ... reduction-oxidation reactions underlie a variety of cell functions ... to these crucial roles in regulating normal cellular ...
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... Analyzer and VetScan Canine Heartworm Rapid Test at the ... 16 Abaxis, Inc. (Nasdaq: ABAX ... instruments for both the medical and veterinary markets, announced ... Coagulation Analyzer and VetScan Canine Heartworm Rapid Test ...
... Direct Sales Model in Guangdong ProvincePROVO, Utah, Jan. 15 ... ) announced today that it has received official notification ... to commence direct selling activities in four cities in ... approval gives Nu Skin Enterprises the opportunity to offer ...
... cognition suffers as nervous system network decays with aging ... matter" that connects the regions of the brain may ... loss than previously believed, a new study says. ... healthy young and old adults, Massachusetts Institute of Technology ...
... Mich., Jan. 15 Dr. Brett Kotlus is the,first ... and,tissue glue to lift the brow for facial rejuvenation. ... brow-lifting techniques. Cosmetic,surgeons are using multiple new medical devices ... Kotlus, of Allure Medical Spa, presented his ...
... /PRNewswire-FirstCall/ - QLT Inc. ("QLT") (NASDAQ: QLTI ; ... its modified "Dutch Auction" tender offer (the "Offer") for up ... on December 5, 2008. The Offer, which was to expire ... 5:00 p.m. (Eastern time) on January 26, 2009, unless further ...
... to Be Held on Martin Luther King Day in ... DC at the Martin Luther King Library ... relief organization, announced today that on Martin Luther King Jr. Day, ... against hunger with Martin Luther King III, David Arquette, and musical ...
Cached Medicine News:Health News:ABAXIS Announces Launch of Two New Products at the NAVC 2Health News:ABAXIS Announces Launch of Two New Products at the NAVC 3Health News:Nu Skin Enterprises Receives Broader Direct Selling Authorization in China 2Health News:Looking Years Younger, Raising a Few Brows 2Health News:QLT announces new expiration date of tender offer 2Health News:QLT announces new expiration date of tender offer 3Health News:Feeding America, Martin Luther King III, David Arquette, Josh Groban and Herbie Hancock Join Forces to Combat Hunger in America on Presidential Inaugural Committee National Day of Service 2Health News:Feeding America, Martin Luther King III, David Arquette, Josh Groban and Herbie Hancock Join Forces to Combat Hunger in America on Presidential Inaugural Committee National Day of Service 3
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Texas--(BUSINESS WIRE)--Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) ... of Proellex(TM), an oral drug being developed to,relieve ... with Proellex results in a statistically highly,significant improvement ... well tolerated., Study Details and Results , This ...
... Arrowhead Research,Corporation (NASDAQ: ARWR) announced the publication ... a study,demonstrating the anti-proliferative effect of the ... its lead anti-cancer,compound, CALAA-01., The paper, entitled ... Reduce Cell Proliferation In vitro and In,vivo", ...
Cached Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
The Universal Wrist/Forearm Splint is ideal for post-surgical immobilization, post-fracture casting, wrist sprains and strains....
Designed to provide comfortable support, protection and immobilization MCP joint along with immobilization of the wrist...
Provides secure fracture immobilization while allowing for full range of motion at elbow and wrist...
... UNO Splint fits small, medium, and large - ... includes both dorsal and volar stays with D-ring ... those experiencing symptoms of Carpal Tunnel Syndrome, sprains ... - stock one splint to comfortably fit a ...
Medicine Products: